trans-Tranilast

  Cat. No.:  DC8295   Featured
Chemical Structure
70806-55-2
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
trans-Tranilast (trans-MK-341) is an antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis.
Cas No.: 70806-55-2
Chemical Name: trans-Tranilast
Synonyms: trans-Tranilast;2-{[(2E)-3-(3,4-Dimethoxyphenyl)-2-propenoyl]amino}benzoic acid;(3',4'-dimethoxycinnamoyl)-anthranilic acid;(3.4-Dimethoxy-benzal)-anthranilsaeure;(3.4-Dimethoxy-benzyliden)-anthranilsaeure;(E)-2-{[3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl]amino}benzoic acid;2-(3,4-dimethoxycinnamoylamino)benzoic acid;2-(3.4-Dimethoxy-benzalamino)-benzoesae;AC1L86AG;N-(3,4-dimethoxybenzylidene)anthranilic acid;NSC405414;N-veratryliden-anthranilic acid;tranilast (N-(3',4'-dimethoxycinnamoyl)anthranilic acid);N-5';N-5';AB00382987-19;AB00382987-19;NCGC00261878-01;NCGC00261878-01;53902-17-3;53902-17-3;SMR000058373;SMR000058373;NCGC00021458-04;NCGC00021458-04;HMS3648A16;HMS3648A16;AB00382987_21;AB00382987_21;NC00171;NC00171;MK 341;SB 252218;MK 341;SB 252218;N-(3 ,4 -dimethoxycinnamoyl)anthranilic acid;N-(3 ,4 -dimethoxycinnamoyl)anthranilic acid;N-(3,4-Dimethoxycinnamoyl)anthranilic acid;N-(3,4-Dimethoxycinnamoyl)anthranilic acid;2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino] benzoic acid;2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino] benzoic acid;SDCCGSBI-0051160.P004;SDCCGSBI-0051160.P004;NCGC00018185-06;NCGC00018185-06;DTXCID403693;DTXCID403693;NSC 758970;NSC 758970;Tranilast (trans-);Tranilast (trans-);Q27164069;Q27164069;BD164491;BD164491;HMS2094I21;HMS2094I21;AB00382987-18;AB00382987-18;2-{[(2e)-3-(3,4-Dimethoxyphenyl)prop-2-Enoyl]amino}benzoic Acid;2-{[(2e)-3-(3,4-Dimethoxyphenyl)prop-2-Enoyl]amino}benzoic Acid;HSCI1_000076;SR-01000003092-2;HSCI1_000076;MLS006010043;SR-01000003092-2;MLS001065902;MLS006010043;AMY14167;MLS001065902;Rizaben;AMY14167;Rizaben;D27;D27;Tranilastum [INN-Latin];Tranilastum [INN-Latin];n-(3',4'-dimethoxycinnamoyl) anthranilic acid;n-(3',4'-dimethoxycinnamoyl) anthranilic acid;AC-940;Q2325594;AC-940;53902-12-8;Q2325594;GTPL6326;53902-12-8;BCP06359;GTPL6326;KS-1193;BCP06359;s5871;KS-1193;BDBM21613;s5871;Rizaben (TN);BDBM21613;NCGC00018185-10;Rizaben (TN);HMS3713J04;NCGC00018185-10;2-({(2E)-3-[3,4-bis(methyloxy)phenyl]prop-2-enoyl}amino)benzoic acid;HMS3713J04;AC-35254;2-({(2E)-3-[3,4-bis(methyloxy)phenyl]prop-2-enoyl}amino)benzoic acid;HMS3263P07;AC-35254;Benzoic acid, 2-[[3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl]amino]-;HMS3263P07;HMS3412G17;Benzoic acid, 2-[[3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl]amino]-;Tranilastum;HMS3412G17;SB 252218;Tranilastum;2-[3-(3,4-dimethoxyphenyl)prop-2-enoylamino]benzoic acid;SB 252218;SPECTRUM1505333;2-[3-(3,4-dimethoxyphenyl)prop-2-enoylamino]benzoic acid;HMS2230F18;SPECTRUM1505333;NCGC00018185-08;SCHEMBL29875;HMS2230F18;2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propen-1-yl]amino]benzoic Acid;NCGC00018185-08;tranilast;SCHEMBL29875;TRANILAST [INN];2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propen-1-yl]amino]benzoic Acid;BSPBio_003561;tranilast;MK 341;TRANILAST [INN];AKOS002841076;BSPBio_003561;NCGC00018185-23;MK 341;HVF50SMY6E;AKOS002841076;TRANILAST [MART.];NCGC00018185-23;HB...
SMILES: O=C(O)C1=CC=CC=C1NC(/C=C/C2=CC(OC)=C(OC)C=C2)=O
Formula: C18H17NO5
M.Wt: 327.331285238266
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: trans-Tranilast For the detailed information of trans-Tranilast, the solubility of trans-Tranilast in water, the solubility of trans-Tranilast in DMSO, the solubility of trans-Tranilast in PBS buffer, the animal experiment (test) of trans-Tranilast, the cell expriment (test) of trans-Tranilast, the in vivo, in vitro and clinical trial test of trans-Tranilast, the EC50, IC50,and affinity,of trans-Tranilast, For the detailed information of trans-Tranilast, the solubility of trans-Tranilast in water, the solubility of trans-Tranilast in DMSO, the solubility of trans-Tranilast in PBS buffer, the animal experiment (test) of trans-Tranilast, the cell expriment (test) of trans-Tranilast, the in vivo, in vitro and clinical trial test of trans-Tranilast, the EC50, IC50,and affinity,of trans-Tranilast, Please contact DC Chemicals.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC31074 Isopropyl myristate Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC74557 PREX-in1 PREX-in1 is a specific small-molecule inhibitor of P-Rex1 and P-Rex2 Rac-GEF activity with IC50 of 4.5 uM (P-Rex1 DHPH Rac-GEF activity) in liposome-based GEF assay, inhibits P-Rex1 and P-Rex2 through their catalytic DH domain.
DC74555 GYS32661 GYS32661 (GYS 32661) is a potent Rac inhibitor capable of inhibiting both Rac1 and Rac1b, inhibited activated Rac1 with IC50 of 1.18 uM in in vitro pull-down assays.
DC74539 L557-0155 L557-0155 is a small molecule inhibitor of VSIG-8, prevents VSIG-8 binding to VISTA, promotes cytokine production and cell proliferation in PBMCs and suppresses melanoma growth.
DC74528 K284 K284 is a selective small molecule inhibitor of chitinase 3 like1 (CHI3L1) with strong binding affinity (Kd=-9.7 kcal·mol-1), inhibits lung metastasis by blocking IL-13Rα2-mediated JNK-AP-1 signals.
DC74225 YB-537 YB-537 (YB537) is a potent, highly specific quinone reductase 2 (QR2) inhibitor with IC50 of 3 nM, shows no activity against QR1 (IC50>10 uM).
DC74223 X-Neu5Ac X-Neu5Ac (sodium) is a substrate for chromogenic assay of neuraminidase activity in bacterial expression systems; with a Km of 0.89 mM for neuraminidase.
DC74218 UT-59 UT-59 is a specific inhibitor of cholesterol-sensing membrane protein Scap, binds to Scap's cholesterol-binding site, blocks SREBP activation and inhibits lipid synthesis.
DC74205 Tryptolinamide Tryptolinamide (TLAM) is a small-molecule compound that activates mitochondrial respiration in cybrids generated from patient-derived mitochondria and fibroblasts from patient-derived iPSCs, inhibits phosphofructokinase-1 (PFK1) with an ATP-uncompetitive
DC74203 TR-107 TR-107 (TR107) is a highly potent, selective and orally bioavailable small-molecule activator of the mitochondrial protease ClpP with EC50 of 140 nM, binds to purified ClpP with Kd value of 180 nM in surface plasmon resonance (SPR) measurement.
X